Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
Authors
Keywords
Regorefenib, Platelets, HCC, Apoptosis, Growth, Invasion
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-05-21
DOI
10.1186/1471-2407-14-351
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversibility of regorafenib effects in hepatocellular carcinoma cells
- (2013) Rosalba D’Alessandro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Thrombocytosis and Hepatocellular Carcinoma
- (2013) Brian I. Carr et al. DIGESTIVE DISEASES AND SCIENCES
- The platelet–cancer loop
- (2013) Hadi A. Goubran et al. European Journal of Internal Medicine
- Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
- (2013) Christophe Louandre et al. INTERNATIONAL JOURNAL OF CANCER
- Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
- (2013) Reiko Nishihara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PDGF α receptor is a mediator for Cisplatin-induced Met expression
- (2012) Shinichiro Kina et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tumor-platelet interaction in solid tumors
- (2012) Daniel Buergy et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of IGF-IR increases chemosensitivity in human colorectal cancer cells through MRP-2 promoter suppression
- (2012) Ke Shen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition, quiescence, and recovery
- (2012) Brian I. Carr et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Paraneoplastic Thrombocytosis in Ovarian Cancer
- (2012) Rebecca L. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells
- (2012) Ting Zhou et al. TUMOR BIOLOGY
- Targeting platelet function to improve drug delivery
- (2012) Mélanie Demers et al. OncoImmunology
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor-Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells
- (2011) Y. Liu et al. Cancer Prevention Research
- Increased Efficacy of Breast Cancer Chemotherapy in Thrombocytopenic Mice
- (2011) M. Demers et al. CANCER RESEARCH
- Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
- (2011) Satoshi Shimizu et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer
- (2011) Kazuhito Sasaki et al. WORLD JOURNAL OF SURGERY
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
- (2010) Hayato Hikita et al. HEPATOLOGY
- The platelet contribution to cancer progression
- (2010) N. M. BAMBACE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma
- (2010) A. Galmiche et al. MOLECULAR CANCER RESEARCH
- Beyond Clotting: The Powers of Platelets
- (2010) M. Leslie SCIENCE
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting insulin-like growth factor type 1 receptor in cancer therapy
- (2009) Francesco Atzori et al. Targeted Oncology
- The role of platelet activation in tumor metastasis
- (2008) Lubor Borsig Expert Review of Anticancer Therapy
- Platelet-derived microparticles promote invasiveness of prostate cancer cellsviaupregulation of MMP-2 production
- (2008) Olga Dashevsky et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started